Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

关于 Lite Strategy

成立时间2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
社区
Twitter
Website
标签
Publicly listed company
Crypto Stocks

热度值变化趋势

暂无数据

团队成员

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

投融资详情

Post-IPO(2025-07-21)
金额¥6.78亿
估值--